Analyst Reco.

06/25/06 Chardan Capital Adjusts Ocugen Price Target to $7 From $6, Maintains Buy Rating MT
22/24/22 Chardan Adjusts Price Target on Ocugen to $5 From $4, Maintains Buy Rating MT
22/24/22 Chardan Raises Price Target on Ocugen to $5 From $4, Keeps Buy Rating MT
24/24/24 HC Wainwright Adjusts Price Target on Ocugen to $7 From $5, Maintains Buy Rating MT
31/23/31 Cantor Fitzgerald Adjusts Ocugen's Price Target to $2 From $2.50, Keeps Overweight Rating MT
08/23/08 Chardan Research Raises Ocugen's Price Target to $4 From $3.50, Buy Rating Kept MT
01/23/01 Chardan Upgrades Ocugen to Buy From Neutral, Citing Recent Sell-Off MT
01/23/01 Mizuho Adjusts Price Target on Ocugen to $3 From $5, Maintains Buy Rating MT
23/22/23 Mizuho Securities Starts Ocugen at Buy With $5 Price Target MT
15/22/15 HC Wainwright Adjusts Ocugen's Price Target to $6 from $7, Maintains Buy Rating MT
15/22/15 Roth Capital Reinstates Ocugen at Buy with $8 Price Target MT
02/22/02 Cantor Fitzgerald Starts Ocugen at Overweight With $4.50 Price Target MT
09/22/09 Chardan Trims Ocugen's Price Targe to $3.50 From $4, Maintains Neutral Rating MT
09/22/09 Chardan Research Adjusts Ocugen's Price Target to $3.50 From $4, Maintains Neutral Rating MT
28/22/28 HC Wainwright Adjusts Ocugen's Price Target to $8 from $10, Maintains Buy Rating MT
14/21/14 Analyst recommendations: Alliant Energy, Ally Financial, Alphabet, HSBC, Honest... Zonebourse
11/21/11 OCUGEN : Chardan Adjusts Ocugen PT to $4.50 From $8, Maintains Neutral Rating MT
11/21/11 OCUGEN : Cantor Fitzgerald Adjusts Ocugen PT to $4 From $11, Maintains Neutral Rating MT
11/21/11 OCUGEN : HC Wainwright Adjusts Ocugen's Price Target to $10 From $12, Maintains Buy Rating MT
11/21/11 OCUGEN : Roth Capital Cuts Ocugen to Neutral From Buy, Price Target to $6 From $10 MT
10/21/10 OCUGEN : Chardan Adjusts Price Target on Ocugen to $8 From $13, Maintains Neutral Rating MT
10/21/10 Today's analyst recommendations: Oracle, Facebook, Berkeley, Acushnet, Ocugen, London Stock Exchange, Flutter... Zonebourse
07/21/07 OCUGEN : Cantor Fitzgerald Downgrades Ocugen to Neutral From Overweight, Adjusts PT to $11 From $15 MT
03/21/03 OCUGEN : Cantor Fitzgerald Adjusts Ocugen PT to $15 From $4, Maintains Overweight Rating MT
09/21/09 OCUGEN : Chardan Capital Downgrades Ocugen to Neutral From Buy on Valuation, Adjusts Price Target to $13 From $0.70 MT
No results for this search